What is CD22 gene?

CD22 (CD22 Molecule) is a Protein Coding gene. Diseases associated with CD22 include Refractory Hematologic Cancer and Hairy Cell Leukemia. Among its related pathways are BCR signaling pathway and Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.

What is CD22 a marker for?

CD22 has been previously characterized as an activation marker of mature B lymphocytes. However, we found that CD22 is expressed early during the ontogeny of B cells in the bone marrow and spleen, and was found on B cells isolated from all the different lymphoid compartments.

What cell types express CD22?

B-cell leukemias
CD22 is expressed on the surface of most B-cell leukemias and lymphomas and therefore has been explored as a target for Ab-based therapies [reviewed by (113, 114)]. The first fully-humanized anti-CD22 IgG1 antibody, Epratuzumab (Emab) has been evaluated in clinical trials of B-cell NHL and ALL (113).

What do CD19 cells do?

CD19 plays two major roles in human B cells: on the one hand, it acts as an adaptor protein to recruit cytoplasmic signaling proteins to the membrane; on the other, it works within the CD19/CD21 complex to decrease the threshold for B cell receptor signaling pathways.

What is CD22 leukemia?

CD22 is a surface molecule expressed early during the ontogeny of B cells in the bone marrow and spleen, and can be found on B cells isolated from the different lymphoid compartments in humans. CD22 is expressed by most blasts from the majority (60–90%) of B-cell acute lymphoblastic leukemia (B-ALL).

Do plasma cells express CD22?

CD22 is a B cell specific glycoprotein that first appears intracellularly during the late pro-B cell stage of ontogeny. Subsequently, CD22 shifts to the plasma membrane with B cell maturation until plasma cell differentiation. Plasma cells do not express the molecule.

What cells express CD20?

CD20 (cluster of differentiate 20) is a protein that is expressed on the surface of B cells, starting at the pre-B cell stage and also on mature B cells in the bone marrow and in the periphery.

What is CD19 deficiency?

CD19-deficient patients have decreased or even no expression of CD19 on the surface of their B cells and an impaired antigen-dependent Ca2+ signaling, resulting in diminished B cell responses upon BCR triggering.

Is CD19 a tumor associated antigen?

Unlike cancers such as ALL or CLL in which the tumor cells universally express the B-cell marker CD19, solid tumors rarely express one tumor specific antigen.

What does CD38-positive mean?

Patients in the CD38-positive cohort were characterised by an unfavourable clinical course with a more advanced disease stage, poor responsiveness to chemotherapy, short time to initiation of first treatment and shorter survival.

What is positive CD20?

CD20 positive T cell lymphoma is a rare condition that is characterized by the coexpression of CD20 and T cell markers, such as, CD3, CD5, or UCHL-11. Positivity for CD20 in any type of T cell lymphoma represents an aberrant immunophenotype, despite the presence of various indicators of T cell lymphoma.

Why is CD20 important?

CD20 is a membrane-embedded surface molecule which plays a role in the development and differentiation of B-cells into plasma cells.

How do B cells become cancerous?

B cells can promote tumor development through the production of autoantibodies and tumor growth factors. Regulatory B cells can directly and indirectly suppress Th1 and CD8+ cytolytic T cell responses. Targeting specific B cell subsets may be of therapeutic value in cancer.

What is CD19 blood test?

CD19 is a biomarker for normal and neoplastic B cells, as well as follicular dendritic cells. CD19 is critically involved in establishing intrinsic B cell signaling thresholds through modulating both B cell receptor-dependent and independent signaling.

What does a low CD19 count mean?

We found that a low CD19% is associated with a nonsignificant 1.2-fold increase in hazard of bacterial infection (95% confidence interval: 0.97, 1.49). In contrast, a high IgG level is associated with a nonsignificant 0.87-fold decrease in hazard of infection (95% confidence interval: 0.68, 1.12).

What is lymphoma B cell?

B-cell lymphoma happens when healthy B-cells change into fast-growing cancer cells that don’t die. The cancer cells duplicate, eventually overwhelming healthy cells. The cancer cells can also spread to other areas of your body including the bone marrow, spleen or other organs.

What is CD23 test?

Identification of follicular dendritic cells. Classification of low-grade B-cell lymphomas. Testing Algorithm. For the initial technical component only immunohistochemical (IHC) stain performed, the appropriate bill-only test ID will be reflexed and charged (IHTOI).

What does CD22 mean?

RNA CD22 (CD22 Molecule) is a Protein Coding gene. Diseases associated with CD22 include Refractory Hematologic Cancer and Hairy Cell Leukemia . Among its related pathways are Downstream signaling events of B Cell Receptor (BCR) and Hematopoietic cell lineage . Gene Ontology (GO) annotations related to this gene include carbohydrate binding .

Where is CD22 found in B cells?

It is found on the surface of mature B cells and to a lesser extent on some immature B cells. Generally speaking, CD22 is a regulatory molecule that prevents the overactivation of the immune system and the development of autoimmune diseases.

What is the relationship between CD19 and CD22?

If phosphorylated by Lyn, CD22 recruits the SHP-1 and SHIP phosphatases, leading to activation of a CD22/SHP-1/SHIP regulatory pathway that downregulates CD19 phosphorylation and BCR mediated signal transduction. Thus, CD19 and CD22 together define signaling thresholds critical for expansion of the peripheral B cell pool [101].

Is CD22 deficiency linked to autoimmune disease?

CD22 has been linked genetically to autoimmune disease indicating a possible role for defects in CD22 and subsequent signaling pathways in the development of autoimmunity. It has been shown that CD22 deficient mice have an expanded B1 cell population and develop increased serum IgM.